Our mission is to bring together engineering, physical sciences, life sciences and medicine to develop innovative ways to address challenges in cancer.

Capturing cancer

on the move

  • Microfabrication and Prototyping Facility - interview with Miguel Hermida Ayala, the facility‚Äôs Lab Manager

    Microfabrication allows researchers to make small scale devices for applications such as microfluidics, organ-on-a-chip, microneedles, and biosensors. To facilitate the development of prototype devices, the Convergence Science Centre has invested in a microfabrication and prototyping facility for researchers at Imperial College London and the Institute of Cancer Research. Supported by a dedicated technician, Miguel Hermida Ayala, the facility can fabricate cleanroom grade bespoke microdevices for pre-clinical in vitro studies. We spoke to Miguel about the key capabilities of the facility, how to get access, training to use the equipment, and some of the exciting convergence science currently underway.
  • Convergence Science PhD - 2021 cohort of students recruited

    Training the next generation of convergence scientists who will develop and accelerate new tools and methodologies into clinical practice to benefit cancer patients is at the heart of the Centre's Convergence Science PhD Programme. Our students are recruited annually through a tailored Recruitment Day, designed specifically to showcase the opportunities in convergence science research and the world leading training environments at Imperial College London and the Institute of Cancer Research. The 2021 Recruitment Day was delivered virtually on February 3rd, and we are pleased to have appointed our fourth cohort of Convergence Science PhD students due to start in October 2021.